The Food and Drug Administration is pledging a reset in the agency’s tobacco program.
Draft U.S. rules would allow soy, oat, almond and other drinks that bill themselves as “milk” to keep using the name.
The U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation.
The head of the Food and Drug Administration has announced an overhaul of the agency's food safety and nutrition division.
The Food and Drug Administration's top food safety official has resigned.
A new report criticizes the Food and Drug Administration’s efforts to oversee the tobacco industry, including traditional cigarettes and vaping products.
The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs.
A panel is calling for changes at the federal agency that oversees most of the nation's food supply, saying revamped leadership, a clear mission and more urgency are needed to prevent illness outbreaks and to promote good health.
A panel of federal advisers says a pregnancy drug intended to prevent premature births should be withdrawn because it doesn't work.
U.S. regulators have revealed their plan to allow foreign baby formula manufactures to stay on the market long term.
The new chief at the Food and Drug Administration's tobacco center has inherited a raft of problems.
U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory.
U.S. health officials are warning doctors against overusing the lone drug available to treat monkeypox.
The head of the Food and Drug Administration says a government review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway.
U.S. regulators have issued a warning letter to the maker of illegal nicotine gummies.
The head of the Food and Drug Administration says a comprehensive review of the opioid painkillers that triggered the nation's ongoing overdose epidemic is in the works.
The head of the Food and Drug Administration is asking for a review of the agency’s food and tobacco programs.
The U.S. is getting another COVID-19 vaccine choice.
Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage.
Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted.
U.S. regulators have historically inspected baby formula plants at least once a year, but they did not inspect any of the three biggest manufacturers in 2020.
Abbott says it's restarted production at the Michigan factory that's tied to the ongoing baby formula shortage.
The head of the Food and Drug Administration testified about a series of setbacks that led to a months-long delay in inspecting the plant at the center of a nationwide baby formula shortage.
The Food and Drug Administration's commissioner says a shuttered baby formula factory could be up and running by next week.
Many questions remain about the shuttered Abbott baby formula plant at the center of a nationwide shortage.
President Joe Biden's administration has announced new steps to ease the national shortage of baby formula, including allowing more imports from overseas.
The Food and Drug Administration has set tentative dates in June to publicly review COVID-19 vaccines for the youngest American children.
The U.S. government has released its long-awaited plan to ban menthol cigarettes and flavored cigars.
Vacant high-ranking positions across the executive branch could be taking a toll on the Biden administration.
The Senate has narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration, filling a position that had been open for more than a year.
President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate.
President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.
President Joe Biden is nominating former Food and Drug Administration commissioner Dr. Robert Califf to again lead the powerful regulatory agency.